Solifenacin succinate
-
Solifenacin succinate
structure -
-
CAS No:
242478-38-2
-
Formula:
C23H26N2O2.C4H6O4
-
Chemical Name:
Solifenacin succinate
-
Synonyms:
Butanedioic acid,compd. with (1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1);2(1H)-Isoquinolinecarboxylic acid,3,4-dihydro-1-phenyl-,(3R)-1-azabicyclo[2.2.2]oct-3-yl ester,(1S)-,butanedioate (1:1);Solifenacin succinate;Vesicare;Vesikur;YM 67905
- Categories:
-
CAS No:
Description
White Solid
Solifenacin succinate is a member of isoquinolines.|A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Characteristics
107
3.67650
1.24g/cm3
~145°
505.5°C at 760 mmHg
259.5ºC
1.648
2.41E-10mmHg at 25°C
201 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NW7136000
|Warning|H302 (95.38%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 65 companies from 10 notifications to the ECHA C&L Inventory.
Drug Information
Treatment of neurogenic detrusor overactivity|Treatment of myoneurogenic bladder disorders
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)|Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-
Solifenacin succinate Use and Manufacturing
Solifenacin succinate is a urinary antispasmodic of the antimuscarinic class.
Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:480.6
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:6
Exact Mass:480.22603674
Monoisotopic Mass:480.22603674
Topological Polar Surface Area:107
Heavy Atom Count:35
Complexity:617
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Competitive muscarinic receptor antagonists inhibit overactivity of the detrusor muscle by blocking the muscarinic M3 receptors of bladder smooth muscle, thereby relieving the symptoms of urge urinary incontinence, urgency and frequency of urination associated with overactive bladder.
Registered Holders
-
MICRO LABS LTD
Active
United States
-
OPTIMUS DRUGS PRIVATE LTD
Active
United States
-
WEIHAI DISU PHARMACEUTICAL CO LTD
Active
United States
Recommended Suppliers of Solifenacin succinate
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Agrochemicals,Daily Chemicals,Catalysts & Chemical Auxiliary Agents,Extract,Inorganic Chemicals,Organic Intermediate,Pigment & Dyestuff,Polymer,Flavour & Fragrance,Basic Organic Chemicals,PharmaceuticalInquiryCAS No.: 242478-38-2Content: 0.00% -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,APIInquiryCAS No.: 242478-38-2Grade: Pharmaceutical GradeContent: 0.00% -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 242478-38-2Grade: Industrial GradeContent: 99%
Latest News on Solifenacin succinate
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
BIS(3,5-DIBROMOSALICYL) SUCCINATE
71337-52-5
-
Methoxypolyethylene glycol succinimidyl succinate
78274-32-5
-
Esreboxetine succinate
635724-55-9
-
Chloramphenicol sodium succinate Formula
982-57-0
-
Dibutyl succinate Formula
141-03-7
-
Methylprednisolone sodium succinate Formula
2375-03-3
-
Desvenlafaxine succinate Structure
386750-22-7
-
Prednisolone sodium succinate Structure
1715-33-9
-
What is Diisoamyl succinate
818-04-2
-
What is 2-Ethyl-6-methyl-3-pyridinyl dimethylcarbamate succinate (2:1)
205189-71-5